Neuberger Berman Group
KERX

Neuberger Berman Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Neuberger Berman Group’s Portfolio KERX Stock Details KERX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,200
Closed -$72K – 1844
2017
Q3 		$72K Buy
10,200
+200
+2% +$1.41K ﹤0.01% 1578
2017
Q2 		$72K Sell
10,000
-1,130
-10% -$8.14K ﹤0.01% 1567
2017
Q1 		$69K Buy
+11,130
New +$69K ﹤0.01% 1566